Advisory: Research alert on Nektar Therapeutics refiled to clarify price target
25/06/2025 10:47
June 25 (Reuters) - A research alert on brokerage H.C. Wainwright raising its price target on Nektar Therapeutics NKTR.O that was published on June 24 has been refiled on June 25 to reflect that the price target is split adjusted. For the correct alert, click here. STORY_NUMBER:AZN40ZW4T STORY_DATE:24/06/2025 STORY_TIME:[041438 GMT] ((bangalore.newsroom@thomsonreuters.com))
Recent news on Nektar Therapeutics
See all newsBrief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment
U.S. STOCKS ON THE MOVEx-Microsoft, 3M, Twilio
U.S. STOCKS ON THE MOVEx-Microsoft, Nike, Nektar Therapeutics
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says